Methylprednisolone Acetate Injection IP 80 mg/2 ml (Mpsone™) is a sterile aqueous injectable suspension supplied in a 2 ml vial. The product contains Methylprednisolone Acetate and is presented for intramuscular, intra-articular or soft-tissue injection, as stated on the product packaging.
Scotmed Care offers Methylprednisolone Acetate Injection IP 80 mg/2 ml for pharmaceutical distribution, hospital/institutional supply and other authorized requirements. Ready product is available—order now for commercial enquiries and bulk requirements.
The product is supplied through a certified WHO-GMP manufacturing facility, supporting consistent pharmaceutical manufacturing and quality-control standards. For buyers searching for a Methylprednisolone Acetate Injection supplier in India, critical care injection company, injectable medicine supplier, WHO-GMP injection manufacturer, or critical care pharmaceutical company, Scotmed Care provides business-oriented supply solutions.
This is a prescription medicine and should be supplied, prescribed and administered only in accordance with applicable regulations and the directions of a qualified healthcare professional.
Product Highlights
- Composition: Methylprednisolone Acetate Injection IP
- Strength: 80 mg/2 ml
- Brand: Mpsone™
- Dosage Form: Injectable Suspension
- Pack: 2 ml Vial
- Form: Sterile Aqueous Suspension
- Route stated on pack: Intramuscular, Intra-Articular or Soft-Tissue Injection
- Ready Product: Available for order
- Manufacturing: Certified WHO-GMP facility
- Business Segment: Critical Care / Injectable Pharmaceutical Products
